NCT00698906View on ClinicalTrials.gov

Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y

PHASE2CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

June 30, 1997

Primary Completion Date

February 28, 1998

Conditions

Hepatitis B

Interventions

BIOLOGICAL

HBV-MPL vaccine

5 different formulations, 2-dose intramuscular injection

BIOLOGICAL

Engerix™-B

3-dose intramuscular injection

Trial Locations (1)

Unknown

GSK Clinical Trials Call Center, Vienna

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY